You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Medtronic
Harvard Business School
Boehringer Ingelheim
Mallinckrodt

Last Updated: February 18, 2020

DrugPatentWatch Database Preview

Patent: 6,372,500

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,372,500
Title: Episomal expression cassettes for gene therapy
Abstract:The invention consists of episomal expression cassettes for expression of a transgene in gene therapy. The expression cassettes consist of regulatory elements of the human cytokeratin gene and a transgene. The invention also includes of liposomes for transfection of epithelial tissue with the cassettes in treatment of cystic fibrosis, emphysema, cancers of epithelial origin arising in the lung or other organs.
Inventor(s): Hu; Jim (East York, CA), Chow; Yu-Hua (North York, CA), O\'Brodovich; Hugh (Oakville, CA), Tsui; Lap-Chee (Etobicoke, CA)
Assignee: HSC Research and Development Limited Partnership (Toronto, CA)
Application Number:09/423,744
Patent Claims:see list of patent claims

Details for Patent 6,372,500

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial HSC Research and Development Limited Partnership (Toronto, CA) 2017-05-14 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial HSC Research and Development Limited Partnership (Toronto, CA) 2017-05-14 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial HSC Research and Development Limited Partnership (Toronto, CA) 2017-05-14 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Moodys
Baxter
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.